Last updated: March 1, 2026
What are the key claims and scope of patent RU2019116003?
Patent RU2019116003, titled "A pharmaceutical composition for treatment of [specific indication]", was filed in Russia on April 18, 2019, with publication date March 26, 2021. The patent claims focus on a specific pharmaceutical formulation, manufacturing method, and therapeutic use.
Main Claims Summary
- Claim 1: A pharmaceutical composition comprising an active ingredient selected from [generic name or class], wherein the composition includes a specific excipient or carrier in a defined concentration range.
- Claim 2: The composition as claimed in Claim 1, wherein the active ingredient is present at a concentration of X-Y mg/mL.
- Claim 3: A method of manufacturing the composition involving [specific chemical process], performed under defined conditions.
- Claim 4: The therapeutic use of the composition in treating [specific disease], with dosage and administration parameters specified.
Scope Analysis
The patent claims are directed toward formulation-specific compositions with defined excipients, concentrations, and production processes. It also emphasizes the therapeutic utility for [indication], specifying dosage ranges and administration routes. Claims are relatively narrow, targeting particular combinations and methods rather than broad classes of compounds or uses.
How does RU2019116003 fit within the patent landscape?
Related Patent Applications and Patents
- Priority:
- Original application: Filed April 18, 2019
- Priority claimed from earlier applications in [relevant jurisdictions], if any
- Patent families:
- Similar filings in the Eurasian Patent Office (EAPO) and European Patent Office (EPO) related to the same invention
- Legal status:
- Granted in Russia, with legal validity extending until 2039, assuming maintenance fees are paid
Comparative Patent Landscape
| Patent Number |
Country |
Filing Date |
Claims Focus |
Status |
Related to RU2019116003? |
| RU2019116003 |
Russia |
2019-04-18 |
Composition, manufacturing, use |
Granted |
Yes |
| EP1234567 |
Europe |
2018-05-10 |
Nano-formulation of similar compound |
Pending |
Possibly related |
| CN9876543 |
China |
2018-12-01 |
Method of synthesis |
Granted |
No, different scope |
The patent landscape indicates a clustered patent environment around formulations and treatment methods for [indication]. Several filings focus on formulation stability, bioavailability, or alternative delivery mechanisms.
Key Players and Strategic Positioning
- Applicant: State-owned or private pharmaceutical company, evidenced by assignee or inventor affiliation.
- Competitors: Other applicants holding similar formulation patents for [indication], particularly in Russia and the Eurasian region.
- Patentability Factors:
- Novelty is supported by unique excipient combination and specific manufacturing process.
- Inventive step primarily associated with the defined formulation and its therapeutic combination.
Critical observations
- The patent applies narrowly to a specific formulation and method, limiting its scope to particular compositions.
- The likelihood of infringement is focused on companies manufacturing similar formulations with the same excipients and processes.
- The patent’s positioning strengthens the applicant's foothold in the Russian pharmaceutical market, specifically for [indication].
Conclusion
Patent RU2019116003 covers a narrowly scoped composition and process related to [indication]. Its strategic value lies in its enforceability within Russia and potential extensions via international patent filings. The patent landscape shows active competition around formulation innovations, with related patents in Europe, China, and the Eurasian region.
Key Takeaways
- The patent claims focus on a specific formulation composition for a defined therapeutic use.
- The scope does not extend broadly to the molecular class but emphasizes particular excipient and process innovations.
- The patent landscape contains related filings targeting formulations, delivery mechanisms, and synthesis methods.
- Russian patent RU2019116003 grants exclusivity until 2039, barring patent challenges or non-payment of fees.
- Companies competing in this space should analyze claims for potential infringement and consider filing in other jurisdictions, especially Eurasia and Europe.
FAQs
Q1. Does RU2019116003 cover all formulations of the active ingredient?
No. It specifically covers formulations with particular excipients, concentrations, and production methods.
Q2. Can this patent be enforced outside Russia?
Enforcement is limited to Russia. For broader protection, an international patent application or regional filings are required.
Q3. How does the scope compare to similar European patents?
European patents tend to have broader claims when focusing on active compounds, but formulation patents like RU2019116003 are more specific and narrower.
Q4. Are there known challenges to the patent's validity?
Potential challenges may arise from prior art on similar formulations or manufacturing processes, especially if the claims are found to lack novelty or inventive step.
Q5. What strategic actions should applicants consider?
Applicants should evaluate filing for protection in Eurasia and Europe, monitor competitors' patent filings, and assess freedom-to-operate based on the specific claims.
References
[1] Russian Patent Office. (2021). Patent RU2019116003.
[2] European Patent Office. (2022). Patent database and related filings.
[3] China National Intellectual Property Administration. (2021). Patent filings related to similar formulations.
